[CAS NO. 1008763-54-9] D-3263hydrochloride
PRODUCTS SPECIFICATIONS [1008763-54-9]
DESCRIPTION [1008763-54-9]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 409.95 |
| Molecular Formula | C21H32ClN3O3 |
| SMILES | [H]Cl.O=C1N(CCN)C2=CC(OC)=CC=C2N1C([C@H]3[C@H](C(C)C)CC[C@@H](C)C3)=O |
Summary
D-3263 hydrochloride is an enteric-coated, orally bioavailable (transient receptor potential melastatin member 8) TRPM8 agonist.
In Vitro
D-3263 hydrochloride binds to and activates TRPM8, which may result in an increase in calcium and sodium entry; the disruption of calcium and sodium homeostasis; and the induction of cell death in TRPM8-expressing tumor cells. D-3263 hydrochloride may decrease dihydrotestosterone (DHT) levels, which may contribute to its inhibitory effects on prostate cancer and BPH [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00839631 | Dendreon |
Solid Tumors
|
March 2009 | Phase 1 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
DMSO : 140 mg/mL ( 341.51 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.4393 mL | 12.1966 mL | 24.3932 mL |
| 5 mM | 0.4879 mL | 2.4393 mL | 4.8786 mL |
| 10 mM | 0.2439 mL | 1.2197 mL | 2.4393 mL |
